Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors

By afschroeder • October 16, 2025

Zhu L, Cheung YM, Chiang C, Gallagher EJ, Hamnvik OR, Mammen J, Quandt Z, Jones R, McDunn J, Al-Bahadili H, Angell T, Bancos I, Betof Warner A, Blackwell S, Calabrese C, Cho TA, Dougan M, Ferreira M, Funchain P, Herndon J, Johnson DB, Kennedy R, Kheterpal M, Khouri M, Lechner MG, Lim AM, Markova A, Meara A, Overton L, Perdigoto AL, Sachithanandan N, Sharon E, Spain L, Tsai K, Yarchoan M, Reynolds KL, Shariff A. Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors. J Immunother Cancer. 2025 Oct 15;13(10):e011865. doi: 10.1136/jitc-2025-011865. PMID: 41093625; PMCID: PMC12530408.

Tags: diabetes, Endocrinology, Hypophysitis, immune checkpoint inhibitor, Immune related adverse event - irAE, Publications, Thyroid toxicity

Exposure to per-and polyfluoroalkyl substances and early-onset cancers

van Gerwen M, Monaghan M, Boni A, Florentino Puello M, Petrick LM, Leung AM. Exposure to per-and polyfluoroalkyl substances and early-onset cancers. Carcinogenesis. 2026 Jul[...]

Risk factors of immune-related adverse events in patients with early-stage breast cancer: Findings from a multi-institutional retrospective study

LeVee A, Jacob S, Fisch S, Face C, Chengappa M, Chaudhry S, Baclig N, Soliman A, Ruel N, Wong M, Tsai K, Kang I, Kordic[...]

Ceramide synthesis mediates colorectal cancer metastasis through a YAP-driven regenerative program

Goswami S, Zhang Q, Yildiz AB, Das Adhikari U, Raghawan AK, Bulliard M, Sedhain S, Darawshi O, Celik CE, Cansiz F, Krempe CP, Rösler J,[...]